Edwards Lifesciences
874 hedge funds and large institutions have $26.8B invested in Edwards Lifesciences in 2018 Q4 according to their latest regulatory filings, with 123 funds opening new positions, 252 increasing their positions, 336 reducing their positions, and 93 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less call options, than puts
Call options by funds: $120M | Put options by funds: $124M
12% less capital invested
Capital invested by funds: $30.6B → $26.8B (-$3.77B)
25% less repeat investments, than reductions
Existing positions increased: 252 | Existing positions reduced: 336
Holders
874
Holding in Top 10
23
Calls
$120M
Puts
$124M
Top Buyers
| 1 | +$409M | |
| 2 | +$260M | |
| 3 | +$173M | |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$169M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$138M |
Top Sellers
| 1 | -$216M | |
| 2 | -$110M | |
| 3 | -$95.2M | |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$81.1M |
| 5 |
O
OrbiMed
New York
|
-$80.4M |